In this CE activity, expert faculty review ongoing clinical trials; evaluate the latest data on the efficacy, safety, and management of nAMD and DME; and summarize the benefits and limitations of sustained delivery systems in the treatment of retinal diseases.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/ophthalmology/20240805/the-retina-radar-with-dr-arshad-khanani/overview
- Start Date: 2024-08-31 05:00:00
- End Date: 2024-08-31 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: Source: AbbVie Inc. - Amount: 2500.0 - Is Kind Support: False Source: Alimera Sciences, Inc. - Amount: 625.0 - Is Kind Support: False Source: Apellis Pharmaceuticals, Inc. - Amount: 937.5 - Is Kind Support: False Source: Astellas - Amount: 1562.5 - Is Kind Support: False Source: EyePoint Pharmaceuticals, Inc. - Amount: 625.0 - Is Kind Support: False Source: Genentech, a member of the Roche Group - Amount: 4062.5 - Is Kind Support: False Source: Neurotech Pharmaceuticals, Inc. - Amount: 625.0 - Is Kind Support: False Source: Ocular Therapeutix, Inc. - Amount: 618.75 - Is Kind Support: False Source: Opthea - Amount: 937.5 - Is Kind Support: False Source: Regeneron Pharmaceuticals, Inc. - Amount: 4687.5 - Is Kind Support: False Source: REGENXBIO Inc. - Amount: 625.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest